Prostaglandin synthesis inhibitors in menorrhagia, intrauterine contraceptive device-induced side effects and endometriosis

Olavi Ylikorkala, O Ylikorkala, Ylikorkala O
Pharmacology & toxicology · 1994 · vol. 75(s2) , pp. 86–88 · doi:10.1111/j.1600-0773.1994.tb02007.x · PMID:7816792 · W2026848700
Review OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Tolfenamic acid, a prostaglandin synthesis inhibitor, effectively prevented or alleviated menorrhagia, IUD side effects, and endometriosis symptoms with good tolerability and no serious side effects.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Primary menorrhagia, IUD side effects and endometriotic symptoms may be a result of excessive PG release in the reproductive organs. These conditions and symptoms can be prevented or markedly alleviated by a PG synthesis inhibitor, such as tolfenamic acid. This treatment, which is used only intermittently, has been well tolerated with no serious side effects.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Cyclooxygenase Inhibitors Endometriosis Menorrhagia ortho-Aminobenzoates Cyclooxygenase Inhibitors Cyclooxygenase Inhibitors Endometriosis Endometriosis Endometriosis Female Female Humans Humans Intrauterine Devices Intrauterine Devices Intrauterine Devices Menorrhagia Menorrhagia Menorrhagia Menorrhagia

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (15)

Cited by (5)

Source provenance

europepmc
last seen: 2026-10-17T06:09:56.316927+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:59:07.256998+00:00
unpaywall
last seen: 2026-10-16T06:24:35.758740+00:00
License: CC0 · commercial use OK